HIV DRUGS
TODAY'S HEADLINES
FDA recently approved an expansion to the prescribing information for darunavir (Prezista), to treat pregnant women with HIV. Most HIV drugs are not indicated for use during pregnancy. Read more |
|
FDA recently approved the New Drug Application (NDA) for lorcaserin HCl CIV extended-release 20 mg tablets (Belviq XR), a once-a-day dosing option for chronic weight management. Read more
|
CONTINUING PHARMACY EDUCATION
This month's CE activity, "Expanding vaccination rates through pharmacist-initiated patient identification and assessment," is open for pharmacists and pharmacy technicians.
The goal of this activity is to educate pharmacists and pharmacy technicians about current vaccine recommendations so that they can identify adolescent and adult patients who may need vaccinations. Readers will also gain knowledge about where to obtain information about current vaccine recommendations.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More
|
EDITOR'S PICK
Expanding access to buprenorphine, a medication to treat opioid use disorder, is one of several new actions announced by Health and Human Services (HHS) to combat the opioid epidemic. Find out the other new guidelines from HHS. Read more
|
|
|
